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mpact of Re-Coarctation Following
he Norwood Operation on Survival
n the Balloon Angioplasty Era
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OBJECTIVES The objective of this study was to determine the efficacy of balloon angioplasty (BA) by
comparing the immediate and long-term outcomes of patients with and without re-
coarctation after a Norwood procedure.
BACKGROUND Although BA has become the standard means for treating recurrent coarctation following a
Norwood operation, it has been suggested that re-coarctation remains a significant cause of
morbidity and mortality.
METHODS Patients who survived a Norwood operation from December 1986 through June 2001 were
studied. Differences between groups were evaluated by t test and logistic regression. Survival
differences were tested by log-rank tests using Kaplan-Meier survival curves.
RESULTS Fifty-eight of 633 patients underwent treatment for re-coarctation (9.2%). Thirty-five
patients underwent BA (before 1988, 23 had surgery). Median age at catheterization was 6.6
months (1.9 to 35.6 months). Balloon angioplasty was successful (gradient 10 mm Hg) in
32 of 35 patients (92%). There were no BA-related deaths or neurologic complications.
Recurrent obstruction after BA occurred in seven patients (20%); five underwent re-dilation.
Kaplan-Meier estimates of freedom from recurrent obstruction after initial BA were 97% at
one month, 79% at one year, and 79% at five years. There were no differences in survival
between patients with re-coarctation treated by BA and patients who did not undergo
treatment for re-coarctation.
CONCLUSIONS We found that 9.2% of patients underwent treatment for re-coarctation following a Norwood
operation. Balloon angioplasty is effective, with low morbidity, no early mortality, and no
difference in long-term survival when compared with patients who did not have re-
coarctation. Recurrent coarctation following BA occurred in 17% of patients, usually within
the first year after BA. (J Am Coll Cardiol 2005;45:1844–8) © 2005 by the American




















He-coarctation is common in patients who have undergone
Norwood operation for hypoplastic left heart syndrome
HLHS), with a reported incidence from 11% to 37% (1–7).
fter the efficacy of balloon angioplasty (BA) was demon-
trated for native and postoperative aortic arch obstruction,
he procedure was applied to patients with HLHS (8–12).
ubsequently, transcatheter BA has become the standard
eans for treating recurrent coarctation in this setting.
everal series have defined the short-term efficacy of this
reatment; however, recurrent obstruction following balloon
ilation is not infrequent, and information regarding the
ong-term outcome of these patients has not yet been
ddressed.
The purpose of this study is to examine the impact of BA
n morbidity and mortality when used as the primary
odality of treatment for re-coarctation following the
orwood operation. First, we evaluated all patients who
From the Divisions of *Cardiology and †Cardiothoracic Surgery, The Children’s
ospital of Philadelphia and the University of Pennsylvania School of Medicine,
hiladelphia, Pennsylvania.d
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ccepted January 4, 2005.nderwent angioplasty for re-coarctation after a Norwood
peration to identify the incidence of and risk factors for
evelopment of re-coarctation of the neo-aorta in patients
fter the Norwood operation. Second, we investigated the
fficacy of BA for treatment of re-coarctation and evaluated
he risk of recurrent obstruction. In doing so, we examined
otential markers to predict initial success and risk factors
or recurrent obstruction as well as the efficacy of repeat BA.
ast, we evaluated the impact of re-coarctation by compar-
ng long-term survival in patients with re-coarctation
reated by BA with survival of patients who underwent a
orwood procedure for HLHS but did not develop subse-
uent arch obstruction.
ETHODS
atient population. We reviewed the surgical database at
he Children’s Hospital of Philadelphia to identify all
atients who underwent a Norwood operation for HLHS
rom December 1986 through June 2001 and survived the
nitial postoperative period (48 h). The diagnosis of
LHS was based on echocardiographic evidence of a
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June 7, 2005:1844–8 Balloon Angioplasty for Re-Coarctationypoplastic left ventricle. Patients undergoing a Norwood
peration for double-outlet right ventricle with mitral atre-
ia and aortic arch hypoplasia, as well as common unbal-
nced atrioventricular canals with left ventricular
ypoplasia-associated arch hypoplasia, were also included
n this study. The institutional review board of the
hildren’s Hospital of Philadelphia approved this retro-
pective study.
Patients presented for cardiac catheterization based on
linical suspicion of arch obstruction or as a routine proce-
ure in anticipation of their next surgical procedure. The
atheterization laboratory database was reviewed to identify
ll patients with re-coarctation after a Norwood operation.
n general, patients were diagnosed with re-coarctation if
hey had a 20 mm Hg gradient and 50% stenosis.
ndividuals with significant angiographic obstruction and
ower gradients in the setting of poor ventricular function
ere also included. The decision to treat arch obstruction
as a clinical one made at the time of evaluation in each
ase. Those who underwent a Norwood procedure and did
ot develop recurrent arch obstruction served as the control
opulation in this study. Variables such as weight at the
ime of the Norwood operation, the presence of native aortic
tresia, and the year during which the Norwood operation
ccurred were examined to identify possible risk factors for
eveloping recurrent arch obstruction.
A technique. All BA procedures occurred under general
nesthesia, both arterial and venous accesses were secured,
nd heparin (100 U/kg) was administered. Standard hemo-
ynamic data were obtained. Biplane aortography was
erformed using one of two projections: 1) straight anterior-
osterior/lateral projections or 2) right anterior oblique with
audal angulation (Fig. 1). Balloon size was determined by
he caliber of the diameter of the descending aorta at the
evel of the diaphragm, and balloon diameters up to 110% of
his diameter were employed. Balloons of varying inflation
ressures were used at the discretion of the cardiologist
erforming the intervention. In the majority of instances,
A was performed via an anterograde approach, although
here were several cases when the arch was dilated in a
etrograde manner. Post-dilation angiograms and proce-
ural records were reviewed to identify all procedural
omplications.
A/immediate success. Before and after procedure hemo-
ynamic measurements were reviewed to determine the
uccess of the intervention. We considered BA to be
uccessful if the final gradient was 10 mm Hg. Multiple
ariables were examined to determine predictors of success
nd included: 1) the patient’s age and weight at the time of
Abbreviations and Acronyms
BA  balloon angioplasty
HLHS  hypoplastic left heart syndromehe BA; 2) the maximum peak systolic gradient pre-BA; 3) whe minimum diameter of narrowing as well as the percent
tenosis compared to the distal aorta at the level of the
iaphragm; 4) the size of the balloon catheter relative to the
egion of narrowing; 5) the approach (anterograde vs.
etrograde) used to perform the BA; and 6) the inflation
ressure (high, 6 atm vs. low, 6 atm) of the angioplasty
alloon.
ncidence of recurrent obstruction. Recurrent coarctation
ollowing initial BA was defined by a persistent peak systolic
radient across the arch 10 mm Hg. Factors from the
nitial BA procedure examined to identify possible predic-
ive variables for recurrent obstruction included: 1) body
urface area at the time of initial presentation; 2) the
resence of native aortic atresia; 3) the initial transaortic
radient; 4) the initial percent stenosis; 5) the balloon
nflation pressure; 6) the ratio of the diameter of the balloon
atheter to narrowest region of stenosis as well as to the
iameter of the aorta at the level of the diaphragm; 7) the
mmediate post-BA gradient; and 8) procedural com-
lications.
ong-term survival. In order to investigate the long-term
mpact of BA as effective treatment for arch obstruction,
urvival rates for patients who underwent BA for re-
oarctation were compared with those of patients who
nderwent a Norwood procedure for HLHS and did not
evelop re-coarctation of their neo-aorta.
tatistical analysis. Continuous variables are expressed as
ean  SD. Comparison of continuous variables was
erformed using paired Student t tests. Categorical variables
ere compared using Fisher exact test. Relationships be-
ween continuous variables were evaluated with simple as
igure 1. A caudally angled antero-posterior projection best profiles the
egion of coarctation in patients after Norwood. Note that the narrowest
egion of the arch is approximately 4 mm in diameter, compared with the
iameter of the lumen of the descending aorta at the level of diaphragm,
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Balloon Angioplasty for Re-Coarctation June 7, 2005:1844–8rom recurrent coarctation following BA was calculated
sing Kaplan-Meier curves. Survival differences between
hose who developed re-coarctation treated by BA and those
ho never developed re-coarctation were compared by
og-rank tests.
ESULTS
etween December 1986 and June 2001, 954 patients with
LHS underwent a Norwood procedure; 633 survived
ore than 48 h after surgery. In 58 patients (9.2%)
e-coarctation of the aorta occurred. The remaining 575
atients served as the control group for this study. Among
he re-coarctation population, 23 patients, all before 1988,
nderwent surgical repair of their neo-aorta and are ex-
luded from this study; the remaining 35 patients under-
ent trans-catheter BA.
The median age at catheterization was 6.6 months (range
.9 to 35.6 months). The average peak systolic gradient was
7.2 mm Hg (range 10 to 70 mm Hg). All patients had
ngiographic evidence of a discrete area of stenosis in the
escending aorta, with an average reduction in the cross-
ectional diameter of 52% (range 21% to 76%).
Of the 35 patients who underwent balloon angioplasty,
1 patients were diagnosed with re-coarctation after the
orwood operation; the remaining four patients had un-
ergone a cavopulmonary anastomosis before diagnosis. In
hese four patients, mild arch obstruction was present at
atheterization before superior cavo-pulmonary connection
average gradient 10 mm Hg; range 7 to 14 mm Hg). Thirty
atients who underwent BA had HLHS (21 of whom had
ortic atresia); the remaining 5 patients had unbalanced
trioventricular canal defects (n  2) or double-outlet right
entricle with mitral atresia or stenosis (n  3). Weight at
he time of the Norwood procedure, the presence of aortic
tresia, or the year during which the surgery was performed
ere not associated with an increased risk for the develop-
ent of re-coarctation.
fficacy of BA. Balloon angioplasty was successful in 32 of
5 patients (92%). The approaches for balloon dilation were
nterograde in 30 patients (86%) and retrograde in five. BA
educed the gradient to an average of 3.9 mm Hg (range 0
o 21 mm Hg). After BA, the residual stenosis accounted
or a total reduction in the cross-sectional diameter of 29%
range 5% to 50%). Complications occurred in seven pa-
ients (20%): two had temporary femoral artery occlusion
esponsive to heparin therapy, two had transient hypoten-
ion, two had ventricular dysrhythmias (ventricular tachy-
ardia), and one developed neo-aortic insufficiency and
ltimately underwent replacement with a prosthetic valve.
here were no BA-related deaths or neurologic com-
lications.
ecurrent obstruction. Recurrent obstruction after bal-
oon dilation occurred in six patients (17%), of whom five
nderwent redilation. All cases of recurrent obstruction
ccurred within the first year following the initial BA. The
f
breedom from recurrence was 79% one and five years after
ngioplasty (Fig. 2). Patients with smaller body surface area
t the time of initial BA were more likely to develop
ecurrent arch obstruction (p  0.03). No other variables
ere associated with recurrent obstruction.
urvival analysis. Kaplan-Meier analysis revealed that sur-
ival of patients with re-coarctation treated by BA was
dentical with control patients. The date of surgery corre-
ated with survival in both groups; other variables such as
he presence of aortic atresia or birth weight did not.
ostoperative survival rates for patients with re-coarctation
ere 93% at 1 year, 73% at 5 years, and 73% at 7.5 years,
ompared with the control group survival rates of 92%, 62%,
nd 62%, respectively (Fig. 3).
ISCUSSION
e-coarctation of the neo-aorta following a Norwood pro-
edure is common (13–16). In a report of 122 necroscopic
eart specimens from patients who died after undergoing a
orwood procedure, re-coarctation was the fourth most
ommon cause of death, occurring in 17 of patients (14%)
17). In our series, re-coarctation occurred in 9.2% of
atients, which is consistent with earlier observational
tudies. We did not find any significant variable that
redisposed patients to develop re-coarctation. In a small
igure 2. Kaplan-Meier curve demonstrates freedom from recurrent ob-
truction after a balloon angioplasty for re-coarctation following the
orwood operation.
igure 3. Kaplan-Meier curves depicting survival beginning six months
fter Norwood. Patients who developed re-coarctation treated by balloon
ngioplasty (BA) are displayed by the solid line, those who never
eveloped re-coarctation by the dashed line. Statistical comparison per-
ormed using the log-rank test demonstrated no difference in survival rates
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June 7, 2005:1844–8 Balloon Angioplasty for Re-Coarctationubset of patients, the first intervention for recoarctation
ccurred after superior cavopulmonary connection. All these
atients had small gradients at catheterization before
econd-stage surgery. The increased gradient in some was
xplained by progressive anatomic obstruction, whereas in
he others it may have related more to interim changes in
emodynamic state.
Our success rate for angioplasty was 92%, which is similar
o previous reports where rates have ranged from 89% to
00% (2,3,7,18). However, when we investigated the longer
erm follow-up of this patient group, we found that recur-
ent obstruction following successful BA occurred in 17% of
atients. Aside from a smaller body surface area at the time
f the initial BA procedure, we could not find any reliable
redictors of recurrent obstruction. We did, however, find
hat when recurrent obstruction occurred, it happened
elatively early and was effectively treated with redilation. In
ur experience, all cases of recurrent coarctation occurred
ithin the first year following initial BA. The freedom from
ecurrent obstruction was 79% thereafter, with an average
ve-year follow-up period.
In our series, the incidence of femoral arterial injury
as significantly lower than previously reported rates
4,10,11,18–20). In the majority of patients, BA of the
oarctation was performed in an anterograde fashion. This
ermits the use of relatively large profile catheters without
he risk of injury to the femoral artery ; in the two instances
here femoral artery occlusion was noted, a retrograde
pproach had been used for dilation. However, it is impor-
ant to note that dilation of the neo-aorta in an anterograde
ashion may carry the risk of injury to the neo-aortic valve.
n our series, one patient developed severe neo-aortic
egurgitation and ultimately required replacement of the
alve with a prosthesis. We believe that complete balloon
eflation before removal from the aorta minimizes the risk
f this complication.
We were interested in determining whether the presence
f re-coarctation affected long-term survival. With a
ollow-up period up to 10 years, we found that that there
as no difference in survival for those treated with BA for
e-coarctation compared with patients who did not have
eo-aortic arch obstruction.
Interpretation of our results is subject to certain limita-
ions. The study population is a preselected group by virtue
f the fact that they all survived the initial months after
orwood in order to undergo a cardiac catheterization.
atients who expired before cardiac catheterization with
e-coarctation were not included. In addition, because there
ere no prospective criteria established for the treatment, or
ven diagnosis, of re-coarctation, indications for dilation
ere not uniform and may have changed over the study
eriod. Given the lack of generally accepted criteria for
e-coarctation after Norwood, we segregated patients based
n treatment for arch obstruction rather than specific
natomic or hemodynamic features. Thus, the control group
ay include some patients with degrees of arch obstruction
1imilar to patients who underwent treatment. The true
ncidence of arch obstruction after Norwood remains un-
nown and will depend on what diagnostic criteria are
pplied. In addition, success was defined as an after-
ngioplasty peak-to-peak gradient of 10 mm Hg after
ilation without reference to systemic blood flow. This may
ave introduced error in our assessment if cardiac output
as significantly lower at the time of the post-angioplasty
ressure measurement. Finally, the relatively small sample
ize in this study limits the power of our analysis.
In summary, our data demonstrate that angioplasty for
e-coarctation of the aorta after Norwood is efficacious with
ow morbidity. Recurrent obstruction may occur within the
rst year, but it is amenable to repeat dilation. Patients with
e-coarctation treated by angioplasty have the same survival
s those without re-coarctation. Future work is needed to
larify, first, the impact of, and then the approach to,
natomic arch obstruction with small or absent pressure
radients in patients after Norwood.
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